The mitigating effect of exogenous carbon monoxide on chronic allograft rejection and fibrosis post-lung transplantation

被引:1
|
作者
Aoki, Yoshiro [1 ,2 ]
Walker, Natalie M. [1 ,2 ]
Misumi, Keizo [1 ,2 ]
Mimura, Takeshi [1 ,2 ]
Vittal, Ragini [1 ,2 ]
McLinden, Aidan P. [1 ,2 ]
Fitzgerald, Linda [4 ]
Combs, Michael P. [1 ,2 ]
Lyu, Dennis [1 ,2 ]
Osterholzer, John J. [1 ,2 ,5 ]
Pinsky, David J. [3 ]
Lama, Vibha N. [1 ,2 ,6 ]
机构
[1] Univ Michigan Hlth Syst, Div Pulm, Ann Arbor, MI USA
[2] Univ Michigan Hlth Syst, Div Crit Care Med, Ann Arbor, MI USA
[3] Univ Michigan Hlth Syst, Div Cardiol, Dept Internal Med, Ann Arbor, MI USA
[4] Univ Michigan Hlth Syst, Dept Pharm Serv, Ann Arbor, MI USA
[5] VA Ann Arbor Hlth Syst, Pulm Sect, Ann Arbor, MI USA
[6] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Dept Internal Med, 1500 W Med Ctr Dr,3916 Taubman Ctr, Ann Arbor, MI 48109 USA
来源
关键词
cGMP signaling; carbon monoxide; sildenafil; lung transplant; mTOR signaling; MESENCHYMAL STEM-CELLS; BETA-CATENIN; ADULT LUNG; FIBROGENESIS; INHIBITION; EXPRESSION; PROTECTS; TARGET; DRIVEN; MODEL;
D O I
10.1016/j.healun.2022.11.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Small airway inflammation and fibrosis or bronchiolitis obliterans (BO) is the predomi-nant presentation of chronic lung allograft dysfunction (CLAD) post-lung transplantation. Carbon mon-oxide (CO) is a critical endogenous signaling transducer with known anti-inflammatory and anti -fibrotic effects but its therapeutic potential in CLAD remains to be fully elucidated. METHODS: Here we investigate the effect of inhaled CO in modulating chronic lung allograft rejection pathology in a murine orthotopic lung transplant model of BO (B6D2F1/J!DBA/2J). Additionally, the effects of CO on the activated phenotype of mesenchymal cells isolated from human lung transplant recipients with CLAD were studied. RESULTS: Murine lung allografts treated with CO (250 ppm pound 30 minutes twice daily from days 7 to 40 post -transplantation) demonstrated decreased immune cell infiltration, fibrosis, and airway obliteration by flow cytom-etry, trichrome staining, and morphometric analysis, respectively. Decreased total collagen, with levels compara-ble to isografts, was noted in CO-treated allografts by quantitative hydroxyproline assay. In vitro, CO (250 ppm pound 16h) was effective in reversing the fibrotic phenotype of human CLAD mesenchymal cells with decreased collagen I and b-catenin expression as well as an inhibitory effect on ERK1/2 MAPK, and mTORC1/ 2 signaling. Sildenafil, a phosphodiesterase 5 inhibitor, partially mimicked the effects of CO on CLAD mesen-chymal cells and was partially effective in decreasing collagen deposition in murine allografts, suggesting the contribution of cGMP-dependent and-independent mechanisms in mediating the effect of CO. CONCLUSION: These results suggest a potential role for CO in alleviating allograft fibrosis and mitigat-ing chronic rejection pathology post-lung transplant. J Heart Lung Transplant 2023;42:317-326 (c) 2022 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:317 / 326
页数:10
相关论文
共 50 条
  • [1] Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival
    Newton, Chad A.
    Kozlitina, Julia
    Lines, Jefferson R.
    Kaza, Vaidehi
    Torres, Fernando
    Garcia, Christine Kim
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (08): : 845 - 853
  • [2] Influence of azithromycin and allograft rejection on the post-lung transplant microbiota
    Spence, Christopher D.
    Vanaudenaerde, Bart
    Einarsson, Gisli G.
    Mcdonough, John
    Lee, Andrew J.
    Johnston, Elinor
    Verleden, Geert M.
    Elborn, J. Stuart
    Dupont, Lieven J.
    Van Herck, Anke
    Gilpin, Deirdre F.
    Vos, Robin
    Tunney, Michael M.
    Verleden, Stijn E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (02): : 176 - 183
  • [3] Chronic lung allograft dysfunction post-lung transplantation: The era of bronchiolitis obliterans syndrome and restrictive allograft syndrome
    Nobuyuki Yoshiyasu
    Masaaki Sato
    World Journal of Transplantation, 2020, (05) : 104 - 116
  • [4] RATE AND TRAJECTORY OF ALLOGRAFT FUNCTION POST-LUNG TRANSPLANTATION
    Gagermeier, James
    Follman, Benjamin
    Hill, Meghan L.
    Joyce, Cara
    CHEST, 2024, 166 (04) : 6334A - 6334A
  • [5] X-ray Velocimetry in Assessing Chronic Lung Allograft Dysfunction Post-lung Transplantation
    Ali, H. A.
    O'Sullivan-Murphy, B.
    Mann, S.
    Buckley, E. Bush
    Frankel, C.
    Britt, A.
    Reynolds, J. M.
    Otvos, T.
    Kirkness, J. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [6] Outcomes of Suspected Antibody-Mediated Rejection Post-Lung Transplantation
    Hirji, A.
    Zhao, H.
    Ospina, M. B.
    Tikkanen, J. M.
    Tinckam, K. J.
    Singer, L. G.
    Chaparro, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S301 - S302
  • [7] The Association of Post-Lung Transplant Pulmonary Embolism With the Development of Chronic Lung Allograft Dysfunction
    Magin, Justin C.
    Xu, Chun
    Peskoe, Sarah
    Dorry, Michael
    Frankel, Courtney W.
    Dahhan, Talal
    Snyder, Laurie D.
    TRANSPLANTATION DIRECT, 2024, 10 (02): : E1572
  • [8] Metformin Attenuates Chronic Lung Allograft Rejection in Rat Lung Transplantation
    Tian, D.
    Zheng, X.
    Huang, H.
    Tang, H.
    Wang, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [9] The common rejection module in chronic rejection post lung transplantation
    Sacreas, Annelore
    Yang, Joshua Y. C.
    Vanaudenaerde, Bart M.
    Sigdel, Tara K.
    Liberto, Juliane M.
    Damm, Izabella
    Verleden, Geert M.
    Vos, Robin
    Verleden, Stijn E.
    Sarwal, Minnie M.
    PLOS ONE, 2018, 13 (10):
  • [10] Pharmacotherapy of chronic lung allograft dysfunction post lung transplantation
    Evans, Rickey A.
    Walter, Krysta S.
    Lobo, Leonard Jason
    Coakley, Raymond
    Doligalski, Christina T.
    CLINICAL TRANSPLANTATION, 2022, 36 (08)